A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.
Senator Cassidy’s political future may be settled, but his role in confirmation hearings can influence the future of health, scientific integrity and trust in government.
Decision fatigue can quietly affect financial judgment, especially for caregivers and women balancing family, health and career responsibilities.
As international travel surges, infectious diseases present a growing concern, especially given how quickly they can spread through modern air travel. We must prepare.
While PBM reforms that passed earlier this year will spur further changes in the way business is conducted, it’s anti-trust legislation that could have the most impact.
Plastic surgeons used to focus on what the eye sees. They are starting to focus on the biology beneath it
Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product listed doesn’t necessarily mean it’s covered.
A radiologist and public health expert breaks down President Trump’s recent physical exam and what questions remained unanswered to the general public.
Microsoft’s Copilot Health preview is live — and it’s heading enterprise. Here’s what healthcare CIOs need to know before it reaches your workforce
With more people using AI chatbots, the question is – how safe are they?